“Let’s say it trades down to a $5 billion valuation,” Schwartz said, throwing out a number more in line with where the London Stock Exchange valued IWG. “Employees will suffer. Investors take a bath. But Adam’s still worth a billion. So from an objective perspective, was it a mistake to play this long con and take on this hemorrhage-inducing risk? You could argue that was the rational mode.”
